Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer (2016)

Peer-Reviewed Study · Wang K; Gao W; Dou Q; Chen H; Li Q; Nice EC; Huang C · December 2016

Wang K et al., 2016-12: Short commentary/autophagic punctum summarising the authors' finding that ivermectin inhibits breast cancer growth by PAK1 degradation, reduced AKT-MTOR signalling and increased autophagic flux in vitro and in vivo.

Ivermectin inhibits the AKT-MTOR signaling pathway by promoting ubiquitination-mediated degradation of PAK1 (p21 [RAC1] activated kinase 1), leading to increased autophagic flux.

n/a (abstract of commentary)

Wang K et al., 2016-12: Short commentary/autophagic punctum summarising the authors' finding that ivermectin inhibits breast cancer growth by PAK1 degradation, reduced AKT-MTOR signalling and increased autophagic flux in vitro and in vivo. Study type: commentary on the group's primary study (cell lines + xenografts). N: n/a. Country: China (West China Hospital, Sichuan University) with co-authors in Australia. Dose: not stated in the abstract. Funder/COI: not stated in the PubMed record. Comparator: n/a. Companion to Dou et al. Cancer Res 2016 (IVC-17); the PMC full text did not load, so the excerpt is from the abstract text of the record. Study type: other.